Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Egetis Therapeutics AB (publ)

Closing information (x1000 EUR)

Closing information 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Turnover 4,013 More Arrow 5,191 Less Arrow 2,031
Financial expenses 2,638 Less Arrow 622 Less Arrow 63
Earnings before taxes -29,879 More Arrow -29,452 More Arrow -17,415
EBITDA -28,372 Less Arrow -28,947 More Arrow -17,559
Total assets 68,977 Less Arrow 68,511 Less Arrow 50,421
Current assets 33,091 Less Arrow 31,173 Less Arrow 13,246
Current liabilities 17,777 Less Arrow 9,364 Less Arrow 4,439
Equity capital 42,911 More Arrow 49,171 Less Arrow 45,488
- share capital 1,776 Less Arrow 1,388 Less Arrow 1,015
Employees (average) 35 Less Arrow 27 Less Arrow 15

Financial ratios

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Solvency 62.2% More Arrow 71.8% More Arrow 90.2%
Turnover per employee 115 More Arrow 192 Less Arrow 135
Profit as a percentage of turnover -744.6% More Arrow -567.4% Less Arrow -857.5%
Return on assets (ROA) -39.5% Less Arrow -42.1% More Arrow -34.4%
Current ratio 186.1% More Arrow 332.9% Less Arrow 298.4%
Return on equity (ROE) -69.6% More Arrow -59.9% More Arrow -38.3%
Change turnover -1,001 More Arrow 3,154 Less Arrow -1,406
Change turnover % -20% More Arrow 155% Less Arrow -41%
Chg. No. of employees 8 More Arrow 12 Less Arrow 4
Chg. No. of employees % 30% More Arrow 80% Less Arrow 36%

Total value of public sale

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.